[Abstract] Retinal degeneration leads to loss of light-sensing photoreceptors eventually resulting in vision impairment and impose a heavy burden on both patients and the society. Currently available treatment options are very limited and mainly palliative. Ever since the discovery of human pluripotent stem cell technologies, cell replacement therapy has become a promising therapeutic strategy for these patients and may help restore visual function. Reproducibly generating enriched retinal cells including retinal progenitors and differentiated retinal neurons such as photoreceptors using human embryonic stem (ES) cells and induced pluripotent stem (iPS) cells in a dish is an essential first step for developing stem cell-based therapies. In addition, this will provide a reliable and sufficient supply of human retinal cells for studying the mechanisms of diseases. Here we describe a small molecule-based retinal induction protocol that has been used to generate retinal progenitors and differentiated retinal neurons including photoreceptors from several human ES and iPS cell lines. The retinal cells generated by this protocol can survive and functionally integrate into normal and diseased mouse retinas for several months following subretinal transplantation.
e. Add 5-7 ml of warm Essential 8 medium (supplied with Rock Inhibitor) dropwise to the 15 ml tube, gently mixing as the medium is added.
f. Centrifuge cells at 270 x g for 3 min at room temperature.
g. Aspirate the medium, leaving the cell pellet intact, gently resuspend the cell pellet in 1 ml of Essential 8 medium (with Rock Inhibitor) using a 2 ml serological pipette, maintain the cells as aggregates.
h. Transfer 0.5 ml of the cell mixture onto a well of a Matrigel-coated 6-well plate containing Essential 8 with Rock Inhibitor (i.e., two wells can be plated from each cryovial).
i. Place the plate in a 37 °C hypoxia-capable incubator (5% CO2, 5% O2), move the plate in several quick, short, back-and-forth and side-to-side motions to evenly distribute the cell aggregates. Do not disturb the plate for 24 h.
Note: Uneven distribution of aggregates may result in increased differentiation of human ES and iPS cells (Figure 2).
j. Perform daily medium changes using Essential 8 medium and visually assess cultures to monitor the growth until the next passaging time. Check for undifferentiated colonies that are ready to be passaged (dense-centered) approximately 6-7 days after thawing ( Figure 1 and Figure 2A 6. Transfer cells into a 15 ml centrifuge tube.
7. Spin at 270 x g for 3 min.
8. Aspirate the supernatant and add 2 ml 1x HBSS and resuspend the cells.
9. Spin at 270 x g for 3 min.
10. Aspirate the supernatant and add NSC + 0.5% FBS medium to resuspend the cells (2 ml per well), usually the splitting ratio is 1:3.
Note: Rock Inhibitor can be added to the medium at the step to help cell survive after dissociation if the cells appear stressed.
11. Add 2 ml of cells in NSC + 0.5% FBS medium into the wells.
12. Put the plate into an incubator (37 °C, 5% CO2) and shake left to right and back and forth to evenly distribute the cells.
13. Cells will be cultured in NSC + 0.5% FBS medium.
14. Change media every 2-3 days as needed. 
Notes
While the protocol works reliably in multiple cell lines tested by our lab. There is some inherent variability due to different culture conditions experienced by various undifferentiated cells or methods of derivation. Authors also advise all labs to routinely test lines for mycoplasma contamination using commercial kits as they significantly affect differentiation capacity. Insulin-like growth factor 1 (IGF1) 50 µl 10 ng/ml R&D Systems
